PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

CEO

Mr. Graydon Bensler C.F.A.

Employees

Country

ISIN

US73017P5089

Listings

0 Comments

Share your thoughts

FAQ

What is PMGC stock price today?▼

The current price of ELAB is $5.27 USD — it has decreased by -62.39% in the past 24 hours. Watch PMGC stock price performance more closely on the chart.

What is PMGC stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange PMGC stocks are traded under the ticker ELAB.

Is PMGC stock price growing?▼

ELAB stock has risen by +166.84% compared to the previous week, the month change is a -27.05% fall, over the last year PMGC has showed a -98.69% decrease.

What is PMGC market cap?▼

Today PMGC has the market capitalization of 3.92M

What is PMGC revenue for the last year?▼

PMGC revenue for the last year amounts to 0 USD.

What is PMGC net income for the last year?▼

ELAB net income for the last year is -12.49M USD.

How many employees does PMGC have?▼

As of April 02, 2026, the company has 2 employees.

In which sector is PMGC located?▼

PMGC operates in the Health Care sector.

When did PMGC complete a stock split?▼

The last stock split for PMGC was on March 10, 2026 with a ratio of 1:6.

Where is PMGC headquartered?▼

PMGC is headquartered in Newport Beach, US.